Page 47 - Product Testing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ABC News Turn on desktop notifications for breaking stories about interest? OffOn Europe starts tests for automated asteroid spotters Scientists say they have switched on a new telescope at the European Southern Observatory as part of an effort to create an automated network for spotting asteroids which might pose a risk to Earth ByThe Associated Press • 2 min read BERLIN -- Scientists said Tuesday they have switched on a new telescope at the European Southern Observatory as part of an effort to create an automated network for spotting asteroids that might pose a risk to Earth. The 56-cent...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ERYTECH Requested a Pre-BLA Meeting with the FDA to Discuss Path to Approval in ALL Erytech Pharma S.A.April 20, 2021 GMT ERYTECH Requested a Pre-BLA Meeting with the FDA to Discuss Path to Approval in ALL ERYTECH invited by FDA to request a pre-BLA meeting First step in the marketing approval process with the FDA for eryaspase for the treatment of hypersensitive ALL patients based on the positive results of the NOPHO-sponsored Phase 2 clinical trial Lyon (France) and Cambridge, MA (U.S.), April 2...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Arcellx Announces Executive Appointments Arcellx, Inc.April 19, 2021 GMT GAITHERSBURG, Md., April 19, 2021 (GLOBE NEWSWIRE) -- Arcellx, a privately held clinical-stage biopharmaceutical company, today announced that it has hired two new executives to join the company’s leadership team. Dr. Christopher Heery has been named Chief Medical Officer (CMO) where he will have responsibility for clinical, regulatory and medical affairs and Neeraj Teotia has been named Chief Commercial Officer where he will...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. European Commission approves second indication of Sarclisa® (isatuximab) for relapsed multiple ... SanofiApril 19, 2021 GMT European Commission approves second indication of Sarclisa® (isatuximab) for relapsed multiple myeloma Approval based on Phase 3 IKEMA study demonstrating Sarclisa added to standard of care carfilzomib and dexamethasone reduced risk of disease progression or death by 47% in patients who had relapsed after one to three prior therapies Sarclisa combination therapy was associat...

Press release content from Accesswire. The AP news staff was not involved in its creation. CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic April 19, 2021 GMT Review process started with submission of first CVnCoV data package TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / April 19, 2021 / The CureVac Swiss AG, the Swiss subsidiary of CureVac N.V. (Nasdaq:CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), today announced initiation of ...